Coagulation Sciences’ Multiple Coagulation Test System

Coagulation Sciences has developed the first medical device to enable caregivers to perform rapid point-of-care analyses of blood clotting during critical procedures that will access the efficacy of multiple treatments.  Branded the Multiple Coagulation Test System (‘MCTS’TM), this desktop device will:

  • Automatically perform 12 blood tests simultaneously for up to 5 blood and coagulation therapies
  • Perform fully automated testing using a single-use disposable Blood Testing Cartridge
  • Provide actionable results in approximately 10 minutes, at the patient’s bedside

MCTS™ Benefits

The MCTS will rapidly compare the ability of multiple therapies to arrest major bleeding at the point-of-care. This will improve patient safety by minimizing, or eliminating, unnecessary blood transfusions and their associated risks. The science underlying the Multiple Coagulation Test System represents the marriage of personalized medicine, evidence-based medicine and Transfusion Management. The result is that individualized therapy will optimize each patient’s blood clotting system. MCTS-supported transfusion decisions will replace protocols designed for general populations with transfusion decisions tailored to each patient’s unique blood disorder.